Onconova Therapeutics, Inc. (ONTX) was a big mover last session, as the company saw its shares rise by over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 11.2% in the past one-month time frame.
The company has seen one positive revision in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Onconova Therapeutics. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
Onconova Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Another biotechnology stock that can be considered is Apricus Biosciences, Inc. (APRI), sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment